Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-07-15
1998-01-27
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A01N 4364
Patent
active
057122776
ABSTRACT:
The present invention relates to the use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable acid addition salts in therapy.
REFERENCES:
patent: 3637688 (1972-01-01), Rees et al.
patent: 4310551 (1982-01-01), Gullo et al.
patent: 4847249 (1989-07-01), Sawyer et al.
Pain 23, (1985) 73-82 Posner et al. "Effects of an Opiate on Cold-induced Pain and the CNS in Healthy Volunteers".
Epilepsia: vol. 27, no. 5, 1986 pp. 490-497; M.J. Leach et al.; "Pharmacological Studies On Lamotrigine, A Novel Potential Antiepileptic Drug: ii. Neurochemical Studies on The Mechanism Of Action".
Neuroscience Letters; vol. 112, No. 2,3 1990; pp. 348-351; E.G. McGeer et al.; "Lamotrigine Protects Against Kainate But Not Ibotenate Lesions In Rat Striatum".
Trends In Pharmcological Sciences; vol. 11; 1990, pp. 307-309; A.H. Dickenson; "A Cure For Wind Up: NMDA Receptor Antagonists As Potential Analgesics".
European Journal of Pharmacology; vol. 187; No. 3, 1990, pp. 513-518; P. Klepstad et al. "Evidence Of A Role For NMDA Receptors In Pain Perception".
Annals of N.York Acad. Of Scien; vol. 648; 1992, pp. 368-370; G.D. Zeevalk et al.; "NMDA Receptors Cellular Edema, And Metabolic Stress And Conference On Neurotoxins And Their Potential Roles In Neurodegeneration" May 8, 1991. N. York.
Advances in Neurology; vol. 52; 1990; pates 219-222; O. Kempski et al. "Intravenous Glutamate Enhances Edema Formation After A Freezing Lesion".
British Journal of Pharmacology; vol. 106, 1992; p. 50P. N. Nakamura-Craig et al.; "Analegesic Effects Of The Glutamate Release Inhibitor, Lamotrigine In The Rat".
British Journ. of Pharmacology; vol. 107, no. supl. 1992; p. 337P; M. Nakamura-Craig et al.; "Analgesic Effects Of Lamotrigine In An Experimental Model Of Neuropathic Pin In Rats".
Advances in Pain Research and Therapy; vol. 7, 1984 pp. 147-151; L.M. Halpern: "Drugs In The Management Of Pain: Pharmacology And Appropriate Strategies Of Clinical Utilization".
Abstract Of The 14Th Annual Meeting Of The European Neuroscience Associate; Cambridge 8-12; Sept. 1991; two pages.
Br. Anaesth; 1989; vol. 63; pp. 139-146; c.J. Woolf: "Recent Advances In The Pathophysiology Of Acute Pain".
Pain; vol. 38; 1989; pp. 91-98; M. Nakamura-Craig et al.; "Substance P and Peripheral Inflammatory Hyperalgesia".
Pain; vol. 42; 1990; pp. 365-371; S.H. Ferreira; "Induction, Blockade And Restoration Of A Persistent Hypersensitive State".
Neuroscience Letters; vol. 124; 1991; pp. 49-51; M. Nakamura-Craig et al.; "Effect Of Neurokinin A, Substance P And Calcitonin Gene Related Peptide In Peripheral Hyperalgesia In The Rat Paw".
European Search Report.
Leach Michael John
Nakamura-Craig Meire
Glaxo Wellcome Inc.
Killos Paul J.
LandOfFree
Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342582